References
- Norris F. H., Engel W. K. Carcinomatous amyotrophic lateral sclerosis. The remote effects of cancer on the nervous system, W. R Brain, F. H Norris. Grune & Stratton, New York 1965; 24–34
- Chio A., Brignolio F., Meineri P., Rosso M. G., Tribolo A., Schiffer D. Motor neuron disease and malignancies: results of a population‐based study. J Neurol 1988; 235: 374–5
- Vigliani M. C., Polo P., Chio A., Giometto B., Mazzini L., Schiffer D. Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis. J Neurol 2000; 247: 778–82
- Verma A., Berger J. R., Snodgrass S., Petito C. Motor neuron disease: a paraneoplastic process associated with anti‐HU antibody and small cell lung carcinoma. Ann Neurol 1996; 40: 112–6
- Khwaja S., Sripathi N., Ahmad B. K., Lennon V. A. Paraneoplastic motor neuron disease with type 1 Purkinje cells antibodies. Muscle Nerve 1998; 21: 943–5
- Moll J. W. B., Vecht Ch J. Paraneoplastic syndromes of the central nervous system. Handbook of Clinical Neurology. Neuro‐oncology, part III, J Vecht Ch. Elsevier Science BV, Amsterdam 1997; volume 25: 349–71
- Evans B. K., Fagan C., Arnold T., Dropcho E. J., Oh S. J. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology 1990; 40: 960–2
- Forman D., Rae‐Grant A. D., Matchett S. C., Cowen J. S. A reversible cause of hypercapnic respiratory failure: lower motor neuropathy associated with renal cell carcinoma. Chest 1999; 115: 899–901
- Brain W. R., Croft P. B., Wilkinson M. Motor neuron disease as a manifestation of neoplasm. Brain 1965; 88: 479–500
- Ferracci F., Fassetta G., Butler M. H., Solimena M., De Camilly P. A novel antineuronal antibody in a motor neuron syndrome associated with breast cancer. Neurology 1999; 53: 852–5
- Berghs S., Ferracci F., Maksimova E., Gleason S., Leszczynski N., Butler M., et al. Autoimmunity to βIV spectrin in paraneoplastic lower motor neuron syndrome. PNAS 2001; 98: 6945–50
- Hays A. P., Roxas A., Sadiq S. A., Vallejos H., D'Agati V., Thomas F. P., et al. A monoclonal IgA in a patient with amyotrophic lateral sclerosis reacts with neurofilaments and surface antigen on neuroblastoma cells. J Neuropath Exp Neurol 1990; 49: 383–98
- Rojas‐Marcos I., Rousseau A., Keime‐Guibert F., Rene R., Cartalat‐Carel S., Delattre J. Y., et al. Spectrum of paraneoplastic neurological disorders in women with breast and gynaecological cancer. Medicine 2003; 82: 216–23
- Forsyth P. A., Dalmau J., Graus F., Cwik V., Rosenblum K., Posner J. B. Motor neuron syndromes in cancer patients. Ann Neurol 1997; 41: 722–30
- Rowland L. P. The causes of sporadic motor neuron disease. Amyotrophic lateral sclerosis, H Mitsumoto, S Prezdborski, P. H Gordon. Taylor & Francis, New York 2005; 81–98
- Corcia P., Honnorat J., Guennoc A. M., de Toffol B., Autret A. Sclérose latérale primitive et cancer du sein: syndrome neurologique para‐néoplasique ou association fortuite?. Rev Neurol. (Paris) 2000; 156: 1020–2
- Trétarre B., Guizard A. V., Fontaine D., and members of the Francin and CepiDc‐Inserm network. Cancer du sein chez la femme: incidence et mortalité, France 2000. BEH 2004; 44: 209–10
- Estève J. Incidence du cancer du sein en France et dans les pays développés. Presse Med 2007; 36: 315–21
- Remontet L., Estève J., Bouvier A. M., Grosclaude P., Launoy G., Ménegoz F., et al. Cancer incidence and mortality in France over the period 1978–2000. Rev Epidemiol Sante Publique 2003; 51: 3–30
- Hirtz D., Thurman D. J., Gwinn‐Hardy K., Mohamed M., Chaudhuri A. R., Zalutski R. How common are the ‘common’ neurological disorders?. Neurology 2007; 68: 326–37
- Forbes R. B., Colville S., Swingler R. J., Scottish ALS/MND Register. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 years or over. Age Ageing 2004; 33: 131–4
- Gordon P. H., Cheng B., Katz I. B., Pinto M., Hays A. P., Mitsumoto H., et al. The natural history of primary lateral sclerosis. Neurology 2006; 66: 647–53